During the past decade, Mount Vernon Cancer Centre at Mount Vernon Hospital conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 20 clinical trials were completed, i.e. on average, 40.8% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 17 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Vernon Cancer Centre at Mount Vernon Hospital" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "University College, London" with 9 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored, "Medical Research Council" with 8 trials sponsored and "Cancer Research UK" with 8 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Vernon Cancer Centre at Mount Vernon Hospital" #1 collaborator was "Cancer Research UK" with 8 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Mount Vernon Cancer Centre at Mount Vernon Hospital" are "Ovarian Cancer" (15 trials), "Breast Cancer" (12 trials), "Fallopian Tube Cancer" (11 trials), "Lymphoma" (10 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "Mount Vernon Cancer Centre at Mount Vernon Hospital" in a lesser frequency.

Most popular intervention types in "Mount Vernon Cancer Centre at Mount Vernon Hospital" are "Drug" (89 trials), "Radiation" (24 trials), "Biological" (23 trials), "Other" (19 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Paclitaxel" (12 trials), "radiation therapy" (12 trials), "Docetaxel" (7 trials) and "cisplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Mount Vernon Cancer Centre at Mount Vernon Hospital" are 87 trials for "All" genders, 27 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Mount Vernon Cancer Centre at Mount Vernon Hospital". 1 are not yet recruiting, 17 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Mount Vernon Cancer Centre at Mount Vernon Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Vernon Cancer Centre at Mount Vernon Hospital, 6 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".